Pages that link to "Q33624412"
Jump to navigation
Jump to search
The following pages link to Theranostic Biomarkers for Schizophrenia (Q33624412):
Displaying 12 items.
- Short overview on metabolomic approach and redox changes in psychiatric disorders. (Q41791000) (← links)
- Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics (Q61805174) (← links)
- Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis (Q64065935) (← links)
- Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia (Q90296931) (← links)
- Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders (Q90574779) (← links)
- Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways (Q92070536) (← links)
- Copy Number Variation of Satellite III (1q12) in Patients With Schizophrenia (Q92072860) (← links)
- A core collection of pan-schizophrenia genes allows building cohort-specific signatures of affected brain (Q93086744) (← links)
- Glycated Haemoglobin Is Associated With Poorer Cognitive Performance in Patients With Recent-Onset Psychosis (Q96303306) (← links)
- 1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia (Q97886063) (← links)
- EEG microstates as biomarker for psychosis in ultra-high-risk patients (Q98665006) (← links)
- Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond (Q99612947) (← links)